Cogent Biosciences Announces Phase 3 Peak Trial in Patients With Gastrointestinal Stromal Tumors (Gist) Has Completed Enrollment and Advanced Past Interim Futility Analysis
Cogent Biosciences宣佈在胃腸道間質瘤(GIST)患者中進行的3期峯試驗已完成招募並完成中期無效分析。
Cogent Biosciences Announces Phase 3 Peak Trial in Patients With Gastrointestinal Stromal Tumors (Gist) Has Completed Enrollment and Advanced Past Interim Futility Analysis
Cogent Biosciences宣佈在胃腸道間質瘤(GIST)患者中進行的3期峯試驗已完成招募並完成中期無效分析。
譯文內容由第三人軟體翻譯。